Holiday Coverage - The CCTG Central Office will be closed on Canada Day, Wednesday, July 1st and will be open with coverage of critical activities on Thursday July 2nd and Friday July 3rd due to Queen's University wide holidays. All regular web-based applications (i.e. MANGO, GCP) will continue to be available. Regular business hours will resume on Monday, July 6 at 8:30 am EST. Have a safe and Happy Canada Day!

Wednesday, July 1 - CLOSED | Thursday, July 2 - OPEN - 9:00am – 5:00pm (limited coverage team) | Friday, July 3 - OPEN - 9:00am – 5:00pm (limited coverage team)

  For the latest COVID-19 (Coronavirus) information: CCTG public updates | CCTG member information

Group newsletter: CCTG Connection

Archived Bulletins

June 24, 2020

Published: June 24, 2020
Category: News

CCTG is pleased to announce that the 2020 CCTG Phase III Team Award for Intergroup-Led trials has been awarded to the Saskatoon Cancer Centre MAC.21 trial team based on the centre's accrual metrics both overall and for this past year, local activation timelines, and compliance metrics. 

The team members include: Nayyer Iqbal, Osama Ahmed, Shahid Ahmed, Tehmina Asif, Kamal Haider, Amer Sami, Mita Manna, Andrea Gallivan, Dominique Wagner, Jolene Hicks.

Read More

Published: June 24, 2020
Category: News

CCTG is pleased to announce that the 2020 CCTG IND Team Award has been awarded to the BCCA Vancouver Centre IND.234 trial team based on the centre's accrual metrics both overall and for this past year, local activation timelines, and compliance metrics. 

The team members include: Kim Chi, Manahil Sadiq, Julita Sienkiewicz, and Wendy Won.

Read More

CCTG is very proud to announce that Dr. Lillian Siu, Princess Margaret Cancer Centre, has been chosen as the recipient of the 2020 International Women Who Conquer Cancer Mentorship Award. Dr. Siu is the director of the Phase I Program, co-director of the Bras and Family Drug Development Program, and clinical lead for the Tumor Immunotherapy Program at Princess Margaret and is Co-Chair of CCTG's Head and Neck Site Committee. She also holds the BMO Chair in Precision Genomics.

Read More

Published: June 24, 2020
Category: News

Two CCTG researchers were recently awarded nearly $2 million from the Canadian Cancer Society and the Conquer Cancer-Breast Cancer Research Foundation to support conduct of CCTG Investigational New Drug trials.

Read More

CCTG is very pleased to announce that Dr. Tim Whelan is the 2020 recipient of the CCTG Founder's Award - Dr. Joseph Pater Excellence in Clinical Trials Research. 

This award honours an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. This individual's research has provided techniques, information or concepts that will direct the future of the oncology research community and CCTG.

Read More

CCTG is very pleased to announce that Dr. Dan Renouf has been awarded the CCTG Dr. Ralph Meyer Phase III Program Young Investigator Award.

This award honours young investigators who have contributed significantly on CCTG phase III projects with CCTG Disease Site Committees, Endpoint Committees, or Working Groups.

“I’m very honored to both be nominated for and to receive this award. The mentorship provided to me by many members within CCTG is very much appreciated," says Dr. Renouf.

Read More

CCTG is very pleased to announce that Dr. Sara Taylor is the 2020 recipient of the Dr. Elizabeth Eisenhauer Early Drug Development Young Investigator Award.  

This award honours young investigators who have participated in the Investigational New Drug (IND) Program and have significantly contributed to IND trial conduct within their institution. Individuals are nominated by their colleagues and the IND Director/Executive Committee to determine the awardee.

Read More

CCTG is pleased to announce that the 2020 CCTG Phase III Team Award for CCTG-Led trials has been awarded to the Princess Margaret Cancer Centre HN.10 trial team based on the centre's accrual metrics both overall and for this past year, local activation timelines, and compliance metrics. 

Read More